Patricia S Andrews insider trades: Oncolytics Biotech (ONCY) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patricia reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ONCY | ↑ Buy | 35,400 | $0.86 | $30K | Direct | Feb 13, 2026 (1d) |
| Nov 16, 2021 | GLYC | ↑ Buy | 40,000 | $2.05 | $82K | Direct | Nov 18, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONCY insiders
Open-market trades in the last 12 months
About Patricia S Andrews's insider trades
Patricia S Andrews is a director at Oncolytics Biotech (ONCY). Since Nov 16, 2021, Patricia has reported 2 open-market purchases worth $112K and no sales on SEC Form 4. In the last 12 months: 1 buy ($30K).
Their filings also include grants and awards (18 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.